219 related articles for article (PubMed ID: 27031959)
21. Potent proapoptotic actions of dihydroartemisinin in gemcitabine-resistant A549 cells.
Zhao C; Qin G; Gao W; Chen J; Liu H; Xi G; Li T; Wu S; Chen T
Cell Signal; 2014 Oct; 26(10):2223-33. PubMed ID: 25018064
[TBL] [Abstract][Full Text] [Related]
22. Physalin D inhibits RANKL-induced osteoclastogenesis and bone loss via regulating calcium signaling.
Ding N; Lu Y; Cui H; Ma Q; Qiu D; Wei X; Dou C; Cao N
BMB Rep; 2020 Mar; 53(3):154-159. PubMed ID: 31964464
[TBL] [Abstract][Full Text] [Related]
23. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
Liu C; Guan H; Cai C; Li F; Xiao J
Exp Cell Res; 2017 Mar; 352(2):293-303. PubMed ID: 28209487
[TBL] [Abstract][Full Text] [Related]
24. Dihydroartemisinin, an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells.
Shi X; Wang L; Ren L; Li J; Li S; Cui Q; Li S
Phytother Res; 2019 May; 33(5):1413-1425. PubMed ID: 30873702
[TBL] [Abstract][Full Text] [Related]
25. The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.
Zhao D; Wang Q; Zhao Y; Zhang H; Sha N; Tang D; Liu S; Lu S; Shi Q; Zhang Y; Dong Y; Wang Y; Shu B
Menopause; 2018 Dec; 25(12):1459-1469. PubMed ID: 29944638
[TBL] [Abstract][Full Text] [Related]
26. Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway.
Chen Y; Wang Y; Hu J; Tang Y; Tian Z; Hu W; Zeng F; Tan J; Dai Q; Hou Z; Luo F; Xu J; Dong S
Aging (Albany NY); 2020 Jun; 12(12):11698-11716. PubMed ID: 32527985
[TBL] [Abstract][Full Text] [Related]
27. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.
Cao J; Wang S; Wei C; Lin H; Zhang C; Gao Y; Xu Z; Cheng Z; Sun WC; Wang HB
Int Immunopharmacol; 2021 Jan; 90():107137. PubMed ID: 33199235
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of vanillin on RANKL-induced osteoclast formation and function through activating mitochondrial-dependent apoptosis signaling pathway.
Chen Y; Dou C; Yi J; Tang R; Yu T; Zhou L; Luo W; Liang M; Yin X; Li J; Kang F; Zhao Y; Dong S
Life Sci; 2018 Sep; 208():305-314. PubMed ID: 30055205
[TBL] [Abstract][Full Text] [Related]
29. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
30. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
Kondo H; Takeuchi S; Togari A
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
[TBL] [Abstract][Full Text] [Related]
31. SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS.
Kim H; Lee YD; Kim HJ; Lee ZH; Kim HH
J Bone Miner Res; 2017 Feb; 32(2):397-406. PubMed ID: 27540894
[TBL] [Abstract][Full Text] [Related]
32. Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells.
Abe K; Yoshimura Y; Deyama Y; Kikuiri T; Hasegawa T; Tei K; Shinoda H; Suzuki K; Kitagawa Y
Int J Mol Med; 2012 Jun; 29(6):1007-15. PubMed ID: 22447156
[TBL] [Abstract][Full Text] [Related]
33. Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors.
Kim HN; Ponte F; Nookaew I; Ucer Ozgurel S; Marques-Carvalho A; Iyer S; Warren A; Aykin-Burns N; Krager K; Sardao VA; Han L; de Cabo R; Zhao H; Jilka RL; Manolagas SC; Almeida M
Sci Rep; 2020 Jul; 10(1):11933. PubMed ID: 32686739
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss.
Park KR; Kim EC; Hong JT; Yun HM
Theranostics; 2018; 8(11):3087-3098. PubMed ID: 29896304
[No Abstract] [Full Text] [Related]
35. Constitutive Activation of β-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice.
Sui X; Deng S; Liu M; Fan L; Wang Y; Xu H; Sun Y; Kishen A; Zhang Q
Cell Physiol Biochem; 2018; 48(5):2091-2102. PubMed ID: 30107384
[TBL] [Abstract][Full Text] [Related]
36. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.
Rahman MM; Bhattacharya A; Fernandes G
J Cell Physiol; 2008 Jan; 214(1):201-9. PubMed ID: 17929247
[TBL] [Abstract][Full Text] [Related]
37. Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
Zhou L; Liu Q; Yang M; Wang T; Yao J; Cheng J; Yuan J; Lin X; Zhao J; Tickner J; Xu J
J Bone Miner Res; 2016 May; 31(5):964-74. PubMed ID: 26684711
[TBL] [Abstract][Full Text] [Related]
38. Ionizing radiation potentiates dihydroartemisinin-induced apoptosis of A549 cells via a caspase-8-dependent pathway.
Chen T; Chen M; Chen J
PLoS One; 2013; 8(3):e59827. PubMed ID: 23536891
[TBL] [Abstract][Full Text] [Related]
39. Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression.
Zhou HJ; Wang Z; Li A
Anticancer Drugs; 2008 Mar; 19(3):247-55. PubMed ID: 18510170
[TBL] [Abstract][Full Text] [Related]
40. Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells.
Qin G; Zhao C; Zhang L; Liu H; Quan Y; Chai L; Wu S; Wang X; Chen T
Apoptosis; 2015 Aug; 20(8):1072-86. PubMed ID: 25935454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
